Breathe Well Live Well
|
KALBITOR(R) (ecallantide) Data Presented at American Academy of Allergy …
MarketWatch (press release) (NASDAQ:DYAX) today announced the presentation of data from KALBITOR(R) (ecallantide) clinical studies in hereditary angioedema (HAE) at the American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting in Orlando, Florida. |
View full post on asthma – Google News
|
KALBITOR(R) (ecallantide) Data Presented at the American College of Allergy …
Trading Markets (press release) Ecallantide for Treatment of Acute Attacks of Acquired C1 Esterase Inhibitor Deficiency — Nisha S. Patel, MD, Asthma Allergy & Pulmonary Associates, … Dyax to present data of KALBITOR inhibitor for Angioedema at ACAAI Meeting |
View full post on asthma – Google News
|
KALBITOR(R) (ecallantide) Data Presented at the American College of Allergy …
istockAnalyst.com (press release) … at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Meeting held November 11-16, at the Phoenix Convention Center in Phoenix, AZ. … KALBITOR(R) (ecallantide) Data Presented at the American College of Allergy … |
View full post on asthma – Google News
|
KALBITOR(R) (ecallantide) Data Presented at the American College of Allergy …
MarketWatch (press release) Ecallantide for Treatment of Acute Attacks of Acquired C1 Esterase Inhibitor Deficiency — Nisha S. Patel, MD, Asthma Allergy & Pulmonary Associates, … KALBITOR(R) (ecallantide) Data Presented at the American College of Allergy … |
View full post on asthma – Google News